Status:
COMPLETED
Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
Lead Sponsor:
Singapore National Eye Centre
Conditions:
Dry Eye
Eligibility:
All Genders
21-99 years
Brief Summary
Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are chronic systemic autoimmune diseases that have been reported to affect the ocular surface of patients \[1,2\]. However, the nature ...
Detailed Description
Background and Rationale Inflammatory autoimmune disease and eye involvement Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are chronic systemic autoimmune diseases of unknown etiol...
Eligibility Criteria
Inclusion
- Clinically diagnosed with Rheumatoid Arthritis or Systemic Lupus Erythematosus
Exclusion
- Known history of thyroid disorders (diagnosed by physician).
- No ocular surgery within the last 3 months and LASIK within 1 year.
- Ocular surface diseases such as pterygium, or obvious lid/orbital disease with lagophthalmos.
- Any other specified reason as determined by clinical investigator.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02217137
Start Date
June 1 2014
End Date
September 1 2015
Last Update
November 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore Eye Research Institute
Singapore, Singapore, Singapore, 168751